http://www.strattera.com/index.jsp
Strattera is an FDA approved drug for the treatment of ADHD (Attention Deficit Hyperactivity Disorder). This drug is often used as a second line, which means it is given to patients who are not responding to the normal first-line medications prescribed.
What sets it apart from other ADHD drugs? Strattera is not a stimulant, which reduces the risk that it will be abused or given to someone it’s not prescribed for. This also means it can be used for patients who are not responding to stimulant-type ADHD treatments.
Recent news released this March, announces Pharmac has approved funding for this new type of drug, making it the first non-stimulant ADHD medication to receive funding of this kind. With this news and the excitement over reduced addictive properties, we may see an increase of Heathcare Professional using this medication when they suspect misuse of other ADHD prescriptions.
http://www.nzdoctor.co.nz/news?article=c10ca00d-f471-45c8-9287-2429c8478cc5
In 2005 the FDA instructed Eli Lilly (the company that produces Strattera) to add a warning to the product that it can cause liver damage in both adults and children, which could lead to liver failure.
http://www.youtube.com/watch?v=wVAVo8e-kOY
Increased risked of liver damage is given to persons taking other drugs known to induce hepatotoxicity.
https://www.changehealthcare.com/rx_brands/drug_interactions/13796
This post particularly caught my attention because my son has just been prescribed Strattera. Hepatotoxicity is a very scary thing, especially when it can happen to your own child. Our family physician taught us about this drug, but I have learned a little more from reading this blog. I will be sure to be careful when giving my son his medication.
ReplyDeleteI have heard that Strattera has the ability to cause liver damage if not taken with precaution. I will be sure to pass the site on to my friend, who takes strattera.
ReplyDelete